发表论文

发表论文：
 

2023

  1. Gao WH, He JY, Chen L, Meng XQ, Ma YN, Liu C*, Zhang MZ*, Fan KL*, Pang D-W* and Yan XY*. Deciphering the catalytic mechanism of superior superoxide dismutase activity of carbon dot nanozyme. Nature Communications. 2023, 14: 160. (IF: 17.7). https://doi.org/10.1038/s41467-023-35828-2.
  2. Ma YN, Zhao JJ, Cheng LL, Li C, Yan XJ, Deng ZC, Zhang YJ, Liang J, Liu C and Zhang MZ*. Versatile carbon dots with superoxide dismutase-like nanozyme activity and red fluorescence for inflammatory bowel disease therapeutics. Carbon. 2023, 204: 526-537. (IF: 11.3). https://doi.org/10.1016/j.carbon.2023.01.006.
  3. Jia ZZ#, Wei W#, Tu KS, Fang BY*, Zhang MZ*, and Shi LL*. Point-of-care monitoring of dry eye disease using lysozyme in tear based on commercial pregnancy test strips. Sensors and Actuators B-Chemical. 2023, 378: 133179. (IF: 9.22). https://doi.org/10.1016/j.snb.2022.133179
  4. Cao YM, Cheng K, Yang M, Deng ZC, Ma YN, Yan XJ, Zhang YY, Jia ZZ, Wang J, Tu KS*, Liang J* and Zhang MZ*. Orally administration of cerium oxide nanozyme for computed tomography imaging and anti-inflammatory/anti-fibrotic therapy of inflammatory bowel disease. Journal of Nanobiotechnology. 2023, 21: 21. (IF=9.43). https://doi.org/10.1186/s12951-023-01770-0
  5. Zhang YJ#, Gao WH#, Ma YN, Cheng LL, Zhang L, Liu QG, Chen JY, Zhao YR, Tu KS*, Zhang MZ* and Liu C*. Integrating Pt nanoparticles with carbon nanodots to achieve robust cascade superoxide dismutase-catalase nanozyme for antioxidant therapy. Nano Today. 2023, 49: 101768. (IF=19.0). https://doi.org/10.1016/j.nantod.2023.101768
  6. Yan XJ，Meng LZ, Zhang XZ, Deng ZC, Gao BW, Zhang YJ, Yang M, Ma Y, Zhang YY, Tu KS, Zhang MZ*, and Xu QR. Reactive Oxygen Species-Responsive Nanocarrier Ameliorates Murine Colitisby Intervening Colonic Innate and Adaptive Immune Responses. Molecular Therapy. 2023, 31(5):1383-1401. (IF=12.9). https://doi.org/10.1016/j.ymthe.2023.02.017
  7. Zhang YJ#, Zhao JJ#, Zhang LM, Zhao YR, Zhang YY, Cheng LL, Wang D, Liu Cui, Zhang MX*, Fan KL*, and Zhang MZ*. A cascade nanoreactor for enhancing sonodynamic therapy on colorectal cancer via synergistic ROS augment and autophagy blockage. Nano Today. 2023, 49: 101798. (IF: 19.0) https://doi.org/10.1016/j.nantod.2023.101798
  8. Geng XD, Du XC, Wang WJ, Zhang CM, Liu XD, Qu YY, Zhao MW, Li WF, Zhang MZ, Tu KS*, and Li YQ*. Confined cascade metabolic reprogramming nanoreactor for targeted alcohol detoxification and alcoholic liver injury management. ACS Nano. 2023, 17(8): 7443–7455. https://pubs.acs.org/doi/10.1021/acsnano.2c12075
  9. Zhou Y, Yan XJ, Yang M, Ma YN, Zhang YY, Cui ML*, Zhang MZ* and Zhang MX*. Oral delivery of therapeutic andrographolide/carbon monoxide (CO) donor for synergistic treatment of ulcerative colitis by anti-inflammation and pro-resolution. ACS Applied Materials & Interfaces. 2023 15, 30, 36061–36075. https://doi.org/10.1021/acsami.3c09342
  10. Yu H, Zhao HY, Zhang YJ, Hou YM, Li YQ, Zhang YY, Li Cheng, Zhang JJ*, Zhang MZ*, and An Ruifang*. Biomimetic nanoreactors for combinational chemo/chemodynamic therapy of choriocarcinoma through synergistic apoptosis and ferroptosis strategy. Chemical Engineering Journal. 2023, 472: 144690. https://doi.org/10.1016/j.cej.2023.144690
  11. Zhao YR, Xu JW, Zhang YY, Wu F, Zhao W, Li RQ, Zhang MZ*, Zhang YJ*, and Guo Cheng*. Biomimetic redox-responsive prodrug micelles with diselenide linkage for platinum nanozymes augmented sonodynamic/chemo combined therapy of colon cancer. Chemical Engineering Journal. 2023, 472: 144911. https://doi.org/10.1016/j.cej.2023.144911
  12. Zhang YY#, Zhang YJ#, Li RQ, Zhao YR, Zhao W, Wu F, Li C*, Hou YZ*, and Zhang MZ*. Immune adjuvant functionalized biomimetic nanocarriers combine sonodynamic therapy for enhanced cancer immunotherapy. Chemical Engineering Journal. 2023, 476: 145685. https://doi.org/10.1016/j.cej.2023.145685
  13. Ding CG, Wang B, Zheng J, Zhang MZ, Li Y, Shen HH, Guo YC, Zheng BX, Tian PX, Ding XM, and Xue WJ. Neutrophil membrane-inspired nanorobots act as antioxidants ameliorate ischemia reperfusion-induced acute kidney injury. ACS Applied Materials & Interfaces. 2023, 15(34): 40292–40303. https://doi.org/10.1021/acsami.3c08573
  14. Jia ZZ, Zhang YJ, Zhang CY, Wei XY*, and Zhang MZ*. Biosensing intestinal alkaline phosphatase by pregnancy test strips based on target-triggered CRISPR-Cas12a activity to monitor intestinal inflammation. Analytical Chemistry. 2023, 95(37): 14111–14118. https://pubs.acs.org/doi/10.1021/acs.analchem.3c03099
  15. 蔡鹏，张明真，高博雯*。植物源细胞外囊泡在炎症性肠病治疗中的应用[J]. 现代生物技术研究, 2023; 1: (1): 6-11.
  16. Liang YL, Zhang MZ, Zhang YJ *, Zhang MX*. Ultrasound sonosensitizers for tumor sonodynamic therapy and imaging: a new direction with clinical translation. Molecules. 2023, 28(18): 6484. https://doi.org/10.3390/molecules28186484
  17. Jia ZZ#, Liu YN#, Deng ZC, Zhang MZ*, and Tuo Hang*. Carbon dots with light-responsive oxidase-like activity for colorimetric dopamine detection and catalytic mechanism. Frontiers in Chemistry. 2023, 11: 1288418. https://doi.org/10.3389/fchem.2023.1288418
  18. Deng ZC, Ma WQ, Gao BW, Zhu YY, Zhang YJ, Zhang MX, Li RQ, and Zhang MZ*. Metal polyphenol network/cerium oxide artificial enzymes therapeutic nanoplatform for MRI/CT imaging-aided intestinal inflammation management. Nano Today. 2023, 53: 102044. https://doi.org/10.1016/j.nantod.2023.102044
  19. He WF#, Jin J#, Zheng SQ, Zhang H, Gao BW, Zhang MZ*, and He Q*. Plant-derived vesicle-like nanoparticles: clinical application exploration and challenges. International Journal of Nanomedicine. 2023, 18: 5671-5683. https://doi.org/10.2147/IJN.S428647
  20. Ma YN, Deng ZC, Gao BW, Xu CX, Yan XJ, Yang M, Zhang YJ, Tu KS, Zhao JJ*, Xu QR*, and Zhang MZ*. Macrophage-biomimetic liposomes delivery of carbon dots nanozymes ameliorate ulcerative colitis by modulating inflammation pathways and remodeling the redox microenvironment. Chemical Engineering Journal. 2023, 477: 146796. https://doi.org/10.1016/j.cej.2023.146796
  21. Geng HG#, Chen JY#, Tu KS, Wu QS, Gao JH, Zhu QW, Zhang Z, Zhang YJ, Huang DS*, Zhang MZ*, and Xu QR*. Carbon dot nanozymes as free radicals scavengers for the management of hepatic ischemia-reperfusion injury by regulating the liver inflammatory network and inhibiting apoptosis. Journal of Nanobiotechnology. 2023. 
  22. Liu H, Zhang YJ, Zhang MZ, Zhou Y, Yu ZX*, and Zhang MX*. Oral administration of platinum nanoparticles with cascade SOD/CAT catalytic activity to alleviate ulcerative colitis. Journal of Founctional Materials. 2023. 
  23. Lu GR#, Jia ZZ#, Zhang MZ*, and Xu CL*. A Ratiometric Fluorescent Sensor Based on Chelation Enhanced Fluorescence of Carbon Dots for Zinc Ion Detection. Molecules. 2023. 
  24. Liu C, Hu J, Chen YM, Fan X, Gao WH, Cheng LL, Luo QY*, and Zhang MZ*. Carbon dots enhanced peroxidase-like activity of platinum nanozyme. Nanoscale. 2023. 
  25. Yan XJ, Gao BW, Deng ZC, Xu CX, Ma YN, Zhang YJ, Zhang BJ*, and Zhang MZ*. Platelet-inspired nanomedicine platform targeting activated neutrophils alleviates ulcerative colitis by cascade SOD/CAT nanozymes-mediated free radicals scavenging and controlled neutrophils swarming. Nano Today. 2023. 
  26. Li SJ, Meng CT, Hao Q, Dai LY, Shi JH, Xu J, Zhou X, Zhao ST, Yang JF, Kang HF, Hou YZ, Zhang MZ, Ma XB, Tan MQ, and Wu Hao*. A multistage-responsive antibody-delivery strategy to improve immunotherapy for NSCLC brain metastasis by ultrasensitive releasing and tumor-anchoring. Advanced Functional Materials. 2023. 

2022

  1. Yang M, Yang CH, Zhang YJ, Yan XJ, Ma YN, Zhang YY, Cao YM, Xu QR*, Tu KS* and Zhang MZ*. Orally pH-activated "nano-bomb" carrier combined with berberine by regulating gene silencing and gut microbiota for site-specific treatment of ulcerative colitis. Biomaterials Science. 2022, 10(4):1053-1067. (IF=7.59)
  2. Ma YN, Gao WH, Zhang YJ, Yang M, Yang XJ, Zhang YY, Li GY, Liu C*, Xu CL* and Zhang MZ*. Biomimetic MOF nanoparticles delivery of C-dot nanozyme and CRISPR/Cas9 system for sitespecific treatment of ulcerative colitis. ACS Applied Materials & Interfaces. 2022, 14(5), 6358−6369. (IF=10.38) 
  3. Gong LY, Zhang YJ, Zhang YL, Tu KS, Jiao LY, Xu QR, Zhang MZ*and Han SX*. All-in-one biomimetic banoplatform based on hollow polydopamine nanoparticles for synergistically enhanced radiotherapy of colon cancer. Small. 2022, e2107656. (IF=15.15) 
  4. Yan XJ, Yang CH, Yang M, Ma YN, Zhang YY, Zhang YJ, Liu C, Xu QR*, Tu KS* and Zhang MZ*. All-in-one theranostic nano-platform based on polymer nanoparticles for BRET/FRET-initiated bioluminescence imaging and synergistically anti-inflammatory therapy for ulcerative colitis. Journal of Nanobiotechnology. 2022, 20(1): 99. (IF=10.435) 
  5. Liu C#, Yan XJ#, Zhang YJ#, Yang M, Ma YN, Zhang YY, Xu QR*, Tu KS* and Zhang MZ*. Turmeric-derived exosome-like nanovesicles with anti-inflammatory and pro-resolving bioactions for treatment of ulcerative colitis. Journal of Nanobiotechnology. 2022, 20(1):206. (IF=10.435) 
  6. Wei W, Zhang YJ, Li RQ, Cao YM, Yan XJ, Ma YN, Zhang YY, Yang M* and Zhang MZ*. Oral delivery of pterostilbene by L-Arginine-mediated “nano-bomb” carrier for the treatment of ulcerative colitis. International Journal of Nanomedicine. 2022, 17, 603-616. (IF=7.03) 
  7. Xu JW#*, Yan XJ#, Zhang Y, Tu KS, Shen W, Tian ZQ, Zhao W* and Zhang MZ. Tunable paclitaxel release carrier using diselenide-disulfide balance as regulator. Journal of Industrial and Engineering Chemistry. 2022, 109, 359-371. (IF: 6.76)
  8. Zhang MX, Lu N, Li Q, Cui ML*, and Zhang MZ*. Editorial: drugs delivery system based on nanoparticles for inflammation and cancer therapy. Front. Mol. Biosci. 2022, 9: 938348. (IF=6.11)
  9. Fang BY*, Jia ZZ, Liu C, Tu KS, Zhang MZ, Zhang L*. A versatile CRISPR Cas12a-based point-of-care biosensor enabling convenient glucometer readout for ultrasensitive detection of pathogen nucleic acids. Talanta. 2022, 249:123657. (IF: 6.56)
  10. Zhang YJ, Zhao YR, Zhang YY, Liu QG, Zhang MZ*, and Tu KS*. The crosstalk between sonodynamic therapy and autophagy in cancer. Frontiers in Pharmacology. 2022, 13: 961725. (IF: 5.988)
  11. Du CX#, Zhang MZ#, Zhou HT#, Wang WJ, Zhang CM, Qu YY, Li WF*, Liu XD, Zhao MW, Tu KS*, and Li YQ*. Decoy nanozymes enable multi-target blockade of pro-inflammatory cascades to reverse bacterial sepsis. Research. 2022, 9767643. (IF: 11.05)
  12. Liu C, Hu J, Wei XY, Gao WH, Cheng LL, Pan GT, Luo QY*, Yin GZ*, and Zhang MZ. Carbon Nanodots-stabilized platinum nanoparticles with high peroxidase-like activity for versatile applications. Chemical Communications. 2022. (IF: 6.06) (Under review).
  13. Liu C, Wei XX, Zhang MZ, Hildebrandt N, Luo QY* and Jin ZW*. Nucleic acid hybridization enhanced luminescence for rapid and sensitive RNA and DNA based diagnostics. Anal Chem. 2022. (IF: 8.0).
  14. Therapeutic Albumin Nanoparticles Hitchhike Activated Neutrophil Across Vascular Barrier for Subcutaneous and Orthotopic Colon Cancer Therapy (In submission)

2021

  1. Gong LY, Zhang YJ, Liu CC, Zhang MZ* and Han SX*. Application of Radiosensitizers in Cancer Radiotherapy. International Journal of Nanomedicine. 2021; 16: 1083-1102. (IF=6.4) ( Highly cited)
  2. 颜湘冀，张玉洁，张明真*。中性粒细胞在溃疡性结肠炎中的作用机制及靶向治疗策略[J]. 右江医学, 2021; 49(2): 87-91
  3. Jia ZZ, Tu KS, Xu QR, Gao WH, Liu C, Fang BY* and Zhang MZ*. A novel disease-associated nucleic acid sensing platform based on split DNA-scaffolded sliver nanocluster. Analytica Chimica Acta. 2021. (IF=6.558)
  4. Wang XY#, Zhang MZ#, Woloshun R, Yu Y, Lee J, Flores S, Merlin D and Collins J. Oral Administration of Ginger-Derived Lipid Nanoparticles and Dmt1 siRNA potentiates the Effect of Dietary Iron Restriction and Mitigates Pre-Existing Iron Overload in Hamp KO Mice. Nutrients. 2021, 13(5), 1686. (IF=5.717)
  5. Ma YN, Qu XL, Liu C, Xu QR* and Tu KS*. Metal-organic frameworks and their composites towards bio-medical applications. Front. Mol. Biosci. 2021, 8: 805228. (IF=5.25)

2020

  1. An J, Hu YG, Chang K, Li C, Hou XL, Wang GL, Zhang XS, Liu B, Zhao YD* and Zhang MZ*. ROS-Augmented and Tumor-Microenvironment Responsive Biodegradable Nanoplatform for Enhancing Chemo-Sonodynamic Therapy. Biomaterials. 2020; 234: 119761. (IF=10.3)
  2. Fang BY*, Guo P, Yang M, Ma YN, Yan XJ, Jia ZZ, Gao WH, Ahmad S, Xu CL, Liu C and Zhang MZ*. A Novel Fluorescent Enhancing Platform Based on DNA-scaffolded Silver Nanoclusters for Potential Inflammatory Bowel Disease-associated MicroRNA Detection. Talanta. 2020; 218: 121122. (IF=5.3)
  3. Yang CH, Zhang MZ, Lama S, Wang LX and Merlin D. Natural-lipid nanoparticle-based therapeutic approach to deliver 6-shogaol and its metabolites M2 and M13 to the colon to treat ulcerative colitis. Journal of Controlled Release. 2020; 323: 293-310. (IF=7.877)
  4. Yang CH, Zhang MZ, Sung J, Wang LX, Jung Y and Merlin D. Isolation and Characterization of Exosomes from Mouse Feces. Bio-protocol. 2020; 10(8): e3584.
  5. Shi Q, Cheng YH, Dong XM, Zhang M, Pei C and Zhang MZ*. Effects of rhaponticin on retinal oxidative stress and inflammation in diabetes through NRF2/HO-1/NF-kB signaling. Journal of Biochemical and Molecular Toxicology. 2020; e22568. (IF=3.606)
  6. Yang M, Zhang YJ, Ma YN, Yan XJ, Gong LY, Zhang MZ* and Zhang BJ*. Nanoparticle-based therapeutics of inflammatory bowel diseases: the current state and prospects. Journal of Bio-X Research (2020) 3:193–209.
  7. Liu C*, Zhang F, Hu J and Zhang MZ. A mini review on pH-sensitive photoluminescence in carbon nanodots. Frontiers in Chemistry. 

2019

  • Zhang MZ*, Yang CH, Yan XJ, Sung JK, Garg P and Merlin D. Highly Biocompatible Functionalized Layer-by-Layer Ginger Lipid Nano Vectors Targeting P-Selectin for Delivery of Doxorubicin to Treat Colon Cancer. Advanced Therapeutics. 2019; 1900129. (Wiley new journal)
  • Yang M, Zhang F, Yang C, Wang L, Sung J, Garg P, Zhang MZ* and Merlin, D. Oral targeted delivery by nanoparticles enhances efficacy of an Hsp90 inhibitor by reducing systemic exposure in murine models of colitis and colitis-associated cancer. Journal of Crohn's and Colitis. 2019. (IF=7.827)
  • Wang X, Zhang MZ, Flores SR, Woloshun RR, Yang C, Yin L, Xiang P, Xu X, Garrick MD, Vidyasagar S, Merlin D and Collins JF*. Oral Gavage of Ginger Nanoparticle-Derived Lipid Vectors Carrying Dmt1 siRNA Blunts Iron Loading in Murine Hereditary Hemochromatosis. Molecular Therapy. 2019; 27(3):493-506. (IF=8.402)
  • Li C, Yang XQ, Zhang MZ, Song YY, Cheng K, An J, Zhang XS, Xuan Y, Liu B, Zhao YD. In vivo Imaging-Guided Nanoplatform for Tumor Targeting Delivery and Combined Chemo-, Gene-and Photothermal Therapy. Theranostics. 2018; 8(20):5662. (IF=8.063)
  • Zhang MZ*, Xu CL, Wen LQ, Han MK, Xiao B, Zhou J and Merlin D. A hyaluronidase responsive nanoparticle-based drug delivery system for targeting colon cancer cells. Cancer Research. 2016; 76(24), 7208-7218. (IF=8.378)
  • Zhang MZ*, Viennois E, Prasad M, Zhang YC, Wang LX, Zhang Z and Merlin D. Edible ginger-derived nanoparticles: a novel therapeutic approach for the prevention and treatment of inflammatory bowel disease and colitis-associated cancer. Biomaterials. 2016; 101:321-340. (IF=10.273)
  • Zhang MZ, Yu Y, Yu RN, Wan M, Zhang RY and Zhao YD*. Tracking the down-regulation of folate receptor-α in cancer cells through target specific delivery of quantum dots coupled with antisense oligonucleotide and targeted peptide. Small. 2013; 9:4183-4193. (IF=10.856)  
  • Zhang MZ*, Xiao B, Wang H, Han MK, Zhang Z, Viennois E and Merlin D. Edible ginger-derived nano-lipids loaded with doxorubicin as a novel drug-delivery approach for colon cancer therapy. Molecular Therapy. 2016; 24(10):1783-96. (IF=8.402)
  • Zhang MZ*, Xu CL, Liu DD, Han MK, Wang LX and Merlin D. Oral delivery of nanoparticles loaded with ginger active compound, 6-shogaol, attenuates ulcerative colitis and promotes wound healing in a murine model of ulcerative colitis. Journal of Crohn’s and Colitis. 2018; 12(2): 217-229. (IF=7.827)
  • Zhang MZ*, Viennois E, Xu CL and Merlin D. Plant derived edible nanoparticles as a new therapeutic approach against diseases. Tissue Barriers. 2016; e1134415.
  • Zhang MZ*, Collins JF and Merlin D. Do Ginger-derived nanoparticles present an attractive treatment strategy for inflammatory bowel disease? Nanomedicine. 2016; 3035-3037. (IF=4.717)
  • Zhang MZ*, Wang XY, Han MK, Collins JF and Merlin D. Oral administration of ginger-derived nano-lipids loaded with siRNA as a novel approach for efficient siRNA drug delivery to treat ulcerative colitis. Nanomedicine. 2017; 12(16), 1927-1943. (IF=4.717)
  • Zhang MZ, Yu RN, Chen J, Ma ZY and Zhao YD*. Targeted quantum dots fluorescence probes functionalized with aptamer and peptide for transferrin receptor on tumor cells. Nanotechnology. 2012; 23:485104. (IF=3.399)
  • Zhang MZ, Li C, Fang BY, Yao MH, Ren QQ, Zhang L and Zhao YD*. High transfection efficiency of quantum dot-antisense oligonucleotide nanoparticles in cancer cells through dual-receptor synergistic targeting. Nanotechnology. 2014; 25:255102. (IF=3.399)
  • Zhang MZ* and Merlin D. Nanoparticle-Based Oral Drug Delivery Systems Targeting the Colon for Treatment of Ulcerative Colitis. Inflammatory Bowel Diseases. 2018; 24(7):1401-1415. (IF=4.005)